General Dermatology
Eczema
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis

Level Up: Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to Severe Atopic Dermatitis: Results of an Open-label, Efficacy Assessor-Blinded Head-to-Head Phase 3b/4 Study : Episode 2

Composite Scores and Quality of Life: A New Standard for AD Management

September 5, 2024

By Raj Chovatiya, MD, PhD, MSCI
Christopher G. Bunick, MD, PhD

Opinion

Video

Atopic dermatitis experts evaluate the integration of composite scores and quality of life measures as a new benchmark for comprehensive disease management.

EP: 1.Evaluating Treatment Efficacy: Identifying and Managing AD Flares in Systemic Therapy Patients

Now Viewing

EP: 2.Composite Scores and Quality of Life: A New Standard for AD Management

EP: 3.From Trial to Practice: Applying Study Results to Real-World AD Management

EP: 4.Comprehensive Analysis: Upa Outshines Dupi Across Key Measures

Related Content

Exploring the Clinical Impact of Topical Ruxolitinib Cream in Atopic Dermatitis

Article

The Cutaneous Connection: Episode 1- Cannabinoid Use in Dermatology

Podcast

Phase 2 Trial of ADX-629 Underway for Treatment of AD

Article

Dermatologist Shares Insights on Saving the Nail at Annual Meeting

Article

Considering and Improving Patient Quality of Life in Dermatologic Conditions

Article

Spotlighting Women In Dermatology

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777